Brighton Jones’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$212K Sell
11,663
-587
-5% -$10.4K ﹤0.01% 1241
2026
Q2
$196K Buy
12,250
+1,273
+12% +$21.1K ﹤0.01% 1256
2026
Q1
$203K Buy
+10,977
New +$193K ﹤0.01% 1090

Other funds holding TAK

Brighton Jones's TAK Position: Q3 2026 in Review

Brighton Jones reduced its Takeda Pharmaceutical (TAK) stake by 4.8% in Q3 2026, selling an estimated $10.4K and leaving 11,663 shares worth $212K. The position accounts for ﹤0.01% of the portfolio, ranked #1241.

Brighton Jones first reported a position in TAK in Q1 2026 and has held it in 3 quarters since. 346 funds tracked by Wall St. Rank hold TAK as of Q3 2026.

  • Brighton Jones held 11,663 shares of Takeda Pharmaceutical worth $212K as of Q3 2026.
  • Brighton Jones sold 587 Takeda Pharmaceutical shares in Q3 2026, an estimated $10.4K.
  • Takeda Pharmaceutical made up ﹤0.01% of Brighton Jones's portfolio in Q3 2026, its #1241 holding.
  • Brighton Jones first reported a position in Takeda Pharmaceutical in Q1 2026 and has held it in 3 quarters since.
  • 346 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.

Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.